Clinical correlation of toxin and common antigen enzyme immunoassay testing in patients with Clostridium difficile disease

American Journal of Gastroenterology

Volumn 98, Issue 7, 2003, Pages 1569-1572

  Lee, Scott D ^b   Turgeon, David K ^b   Ko, Cynthia W ^b   Fritsche, Thomas R ^b   Surawicz, Christina M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CHILD; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DIAGNOSTIC VALUE; DIARRHEA; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 0038796005     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.07482.x     Document Type: Article

References (12)

1. Fekety R, Kim KH, Brown D, et al. Epidemiology of antibiotic-associated colitis: Isolation of Clostridium difficile from the hospital environment. Am J Med 1981;70:906-8.
2. Alfa MJ, Kabani A, Lyerly D, et al. Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J Clin Microbiol 2000;38:2706-14.
3. Maniar AC, Williams TW, Hammond GW. Detection of Clostridium difficile toxin in various tissue culture monolayers. J Clin Microbiol 1987;25:1999-2000.
4. Lozniewski A, Rabaud C, Dotto E, et al. Laboratory diagnosis of Clostridium difficile-associated diarrhea and colitis. Usefulness of premier cytoclone A+B enzyme immunoassay for combined detection of stool toxins and toxigenic C. difficile strains. J Clin Microbiol 2001;39:1996-8.
5. Vargas SO, Horensky D, Onderdonk AB. Evaluation of a new enzyme immunoassay for Clostridium difficile toxin A. J Clin Pathol 1997;50:996-1000.
6. Landry ML, Topal J, Ferguson D, et al. Evaluation of Biosite Triage Clostridium difficile panel for rapid detection of Clostridium difficile in stool samples. J Clin Microbiol 2001;39:1855-8.
7. Barbut F, Lalande V, Daprey G, et al. Usefulness of simultaneous detection of toxin. A and glutamate dehydrogenase for the diagnosis of Clostridium difficile-associated disease. Eur J Clin Micorbiol Infect Dis 2000;19:481-4.
8. Vanpoucke H, De Baere T, Claeys G, et al. Evaluation of six commercial assays for the rapid detection of Clostridium difficile toxin and/or antigen in stool specimens. Clin Microbiol Infect 2001;7:55-64.
9. Turgeon DK, Novicky TJ, Quick J, et al. Six rapid tests for direct detection of Clostridium diffcile and its toxins in fecal samples compared with the fibroblast cytotoxicity assay. J Clin Microbiol 2003;41:667-70.
10. Barbut F, Kajzer C, Planas N, et al. Comparison of three enzyme immunoassays, a cytotoxicity assay, and toxigenic culture for diagnosis of Clostridium difficile-associated diarrhea. J Clin Microbiol 1993;31:963-7.
11. Kader HA, Piccoli DA, Jawad AF, et al. Single toxin detection is inadequate to diagnose Clostridium difficile diarrhea in pediatric patients. Gastroenterology 1998;115:1329-34.
12. Limaye A, Turegeon D, Cookson B, Fritsche T. Pseudomembranous colitis caused by a toxin A-/B + strain of Clostridium difficile. J Clin Microbiol 2000;38:1696-7.